RGVGX | UGSFX | RGVGX / UGSFX | |
Total Expense Ratio | 0.25 | 0.69 | 36% |
Annual Report Gross Expense Ratio | 0.29 | 0.73 | 40% |
Fund Existence | 16 years | 24 years | - |
Gain YTD | 4.180 | 4.039 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.9B | 22.9B | 100% |
Annual Yield % from dividends | 4.46 | 4.02 | 111% |
Returns for 1 year | 6.10 | 5.63 | 108% |
Returns for 3 years | 3.87 | 2.55 | 152% |
Returns for 5 years | -6.36 | -8.30 | 77% |
Returns for 10 years | 8.84 | 4.57 | 193% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CXH | 7.62 | 0.01 | +0.13% |
MFS Investment Grade Municipal Trust | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
ETH | 24.56 | N/A | N/A |
Grayscale Ethereum Mini Trust ETF | |||
RSPS | 30.60 | -0.15 | -0.49% |
Invesco S&P 500® Eql Wt Cnsm Stapl ETF | |||
YINN | 39.39 | -1.35 | -3.31% |
Direxion Daily FTSE China Bull 3X ETF |